{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:46:51Z","timestamp":1793774811928,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018036","name":"Nippon Shinyaku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpet.2026.103806","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:02:47Z","timestamp":1767772967000},"page":"103806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6064-8067","authenticated-orcid":false,"given":"Kiyoto","family":"Kageyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpet.2026.103806_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.jpet.2026.103806_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.jpet.2026.103806_bib3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103806_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jpet.2026.103806_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jpet.2026.103806_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jpet.2026.103806_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104036","article-title":"Updates for the treatment of EGPA","volume":"49","author":"Raffray","year":"2020","journal-title":"Presse Med"},{"issue":"20","key":"10.1016\/j.jpet.2026.103806_bib8","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jpet.2026.103806_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jpet.2026.103806_bib10","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1021\/jm401490p","article-title":"Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases","volume":"57","author":"Clark","year":"2014","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.103806_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Kouro","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.jpet.2026.103806_bib12","series-title":"Pyrazolothiazole compound and medicine","author":"Shiba","year":"2015"},{"issue":"4","key":"10.1016\/j.jpet.2026.103806_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/01902140903360353","article-title":"Analysis of pulmonary allergic vasculitis with eosinophil infiltration in asthma model of mice","volume":"36","author":"Yamauchi","year":"2010","journal-title":"Exp Lung Res"},{"issue":"10","key":"10.1016\/j.jpet.2026.103806_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/rheumatology\/kep209","article-title":"Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg\u2013Strauss syndrome","volume":"48","author":"Jakiela","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jpet.2026.103806_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.09.011","article-title":"Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma","volume":"125","author":"Kelly","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jpet.2026.103806_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jpet.2026.103806_bib17","first-page":"1","article-title":"Tofacitinib suppressed remodeling of pulmonary eosinophilic vasculitis in a murine model","volume":"6","author":"Matsumoto","year":"2020","journal-title":"J Transl Sci"},{"issue":"12","key":"10.1016\/j.jpet.2026.103806_bib18","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1093\/rheumatology\/keaf397","article-title":"Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases","volume":"64","author":"Liu","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jpet.2026.103806_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1546785","article-title":"Effect of anti-interleukin-5 antibody on development of vasculitis in an ovalbumin-induced eosinophilic vasculitis mouse model","volume":"16","author":"Kageyama","year":"2025","journal-title":"Front Pharmacol"},{"issue":"14","key":"10.1016\/j.jpet.2026.103806_bib20","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1182\/blood-2014-08-596361","article-title":"Less Jak2 makes more platelets","volume":"124","author":"Skoda","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jpet.2026.103806_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00125-014-3185-0","article-title":"Adipocyte-specific deficiency of Janus kinase (JAK) 2 in mice impairs lipolysis and increases body weight, and leads to insulin resistance with ageing","volume":"57","author":"Shi","year":"2014","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jpet.2026.103806_bib22","first-page":"348","article-title":"Anatomic, hematologic, and biochemical features of C57BL\/6NCrl mice maintained on chronic oral corticosterone","volume":"62","author":"Cassano","year":"2012","journal-title":"Comp Med"},{"issue":"4","key":"10.1016\/j.jpet.2026.103806_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/1756-185X.12075","article-title":"Effects of imatinib mesylate on pulmonary allergic vasculitis in a murine model","volume":"16","author":"Suzuki","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.jpet.2026.103806_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2332\/allergolint.13-OA-0679","article-title":"Rapamycin attenuates pulmonary allergic vasculitis in murine model by reducing TGF-\u03b2 production in the lung","volume":"63","author":"Koizumi","year":"2014","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.jpet.2026.103806_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/01902148.2016.1157226","article-title":"A phosphatidylinositol 3-kinase inhibitor strongly suppressed pulmonary vascular remodeling of allergic vasculitis in a murine model","volume":"42","author":"Oikawa","year":"2016","journal-title":"Exp Lung Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.103806_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.103806_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1517\/13543784.2013.774373","article-title":"Investigational Janus kinase inhibitors","volume":"22","author":"Tam","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.jpet.2026.103806_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/fon-2016-0417","article-title":"Momelotinib in myelofibrosis: JAK1\/2 inhibitor with a role in treating and understanding the anemia","volume":"13","author":"Winton","year":"2017","journal-title":"Future Oncol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:32:59Z","timestamp":1775014379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022356526000042"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103806","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103806"}}